THEME: "Novel Advancements in Cancer Science and Therapy"
Immodx LLC/ Hangzhou Normal University, Singapore
Title: A 2-gene signature within blood leukocytes as diagnostic biomarkers for early colorectal cancer
Dr
Wang Yu obtained his B.Sc(Hons) in biological sciences from Nanyang
Technological University in 2006 and PhD in biomedical sciences from National
University of Singapore in 2011. He completed his post-doctorate training at
Genome Institute of Singapore before progressing to a Research PI position at
National Cancer Centre Singapore. In his over 15 years of academic research
experience focusing on hepatocellular carcinoma, he has published 17 papers in
reputable international journals such as Nature Communication and Journal of
Hepatology and held five National level grants in Singapore as PI. In 2020, he
turned into an entrepreneur to co-found a biotech startup in China, focusing on
novel diagnostic solutions based on immune signatures. He has since been
awarded the Shaoxing Overseas Innovator Talent Award and China’s National Young
Innovator Award (???). He is now an adjunct professor from Hangzhou Normal University and
recently appointed to the president of the newly established Zhuji
International IVD Innovation Park.